A guide to management of neuropsychiatric manifestations of Parkinson's disease.

CONCLUSIONS: Management of neuropsychiatric manifestations in Parkinson's disease is complicated by the lack of evidence. Treatment should be individualized and benefits and risks must be balanced. PMID: 27329643 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27329643?dopt=Abstract

Source: Australasian Psychiatry - June 20, 2016 Category: Psychiatry Authors: Molina Ruiz RM, Evans AH, Velakoulis D, Looi JC Tags: Australas Psychiatry Source Type: research

More News: Carbidopa/Levodopa | Neurology | Parkinson's Disease | Psychiatry | Study